RAC1 and ovarian cancer: R-ketorolac inhibited Rac1-dependent cellular functions in ovarian cancer cell lines and primary cells including inhibition of growth factor-stimulated formation of filopodia, cell adhesion to fibronectin and type I collagen, development of invadopodia and tumor cell migration [48].